Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06198686 · ClinicalTrials.gov registry record · Phase 1

An Evaluation of The Absolute Bioavailability of TH104

A Phase 1 study of Healthy, sponsored by Tharimmune.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT06198686: Completed Phase 1 study of Healthy, sponsored by Tharimmune.

NCT06198686 is a Phase 1 study of Healthy that has completed, run by Tharimmune. The registered enrollment target is 20 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06198686, a Phase 1 study of Healthy, has completed, sponsored by Tharimmune.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This is a single-dose, single-center, open-label, randomized, 2-way crossover study (2 treatments, 2 periods and 2 sequences) of a buccal formulation of Nalmefene 16 mg and a 1 mg intravenous dose of nalmefene injection, with a least 7 days washout period between doses.

Conditions Studied

Healthy

Interventions

  • DRUG Nalmefene

Study Locations (1)

Nevada

  • Novum Pharmaceutical Research Services - Las Vegas

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-01-26
Est. Completion 2024-11-06
Phase Phase 1

Sponsor

Tharimmune

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06198686

The ClinicalTrials.gov registry entry for NCT06198686 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is Tharimmune, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Nalmefene is the first listed.

NCT06198686 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT06198686 about?

NCT06198686 is a clinical study titled "An Evaluation of The Absolute Bioavailability of TH104". This is a single-dose, single-center, open-label, randomized, 2-way crossover study (2 treatments, 2 periods and 2 sequences) of a buccal formulation of Nalmefene 16 mg and a 1 mg intravenous dose of nalmefene injection, with a least 7 days washout period between doses.

What is the current status of trial NCT06198686?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2024-01-26. Estimated completion is 2024-11-06.

What conditions does trial NCT06198686 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06198686?

The interventions under investigation include: Nalmefene (DRUG).

Who is sponsoring clinical trial NCT06198686?

This trial is sponsored by Tharimmune, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06198686 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Nevada

All trials with a study site in Nevada

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.